Tadliq Interactions
There are 339 drugs known to interact with Tadliq (tadalafil), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 33 are major, 206 are moderate, and 100 are minor.
- View all 339 medications that may interact with Tadliq
- View Tadliq alcohol/food interactions (1)
- View Tadliq disease interactions (10)
Most frequently checked interactions
View interaction reports for Tadliq (tadalafil) and the medicines listed below.
- alpha-lipoic acid
- alprazolam
- ascorbic acid
- benfotiamine
- biotin
- calcium citrate
- cannabis
- chlorophyllin
- choline
- creatine
- DHEA (dehydroepiandrosterone)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- glycine
- iodine / potassium iodide
- l-methylfolate
- lysine
- magnesium glycinate
- NAC (acetylcysteine)
- Niacor (niacin)
- Paxil (paroxetine)
- Pregnyl (chorionic gonadotropin (hcg))
- Remeron (mirtazapine)
- testosterone
- ubiquinone
- vitamin a
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- vitamin e
- Vitamin K2 (menaquinone)
- Zinc plus Copper (copper glycinate/zinc glycinate)
Tadliq alcohol/food interactions
There is 1 alcohol/food interaction with Tadliq (tadalafil).
Tadliq disease interactions
There are 10 disease interactions with Tadliq (tadalafil) which include:
- cardiovascular disease
- renal dysfunction
- pulmonary disease
- priapism
- alcoholism
- hearing loss
- liver disease
- retinitis pigmentosa
- seizure disorders
- Tadalafil-visual disorders
Report options
QR code containing a link to this page
More about Tadliq (tadalafil)
- Tadliq consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: agents for pulmonary hypertension
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
